“abbott-laboratories” Archives

Entry Author Date Location
Wayne State Hires Former Pharma Exec to Lead Tech Commercialization Efforts 02/02/12 Detroit Ann Arbor
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A 12/13/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012 09/29/11 Seattle
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Alder Gets $15M From Bristol 06/20/11 Seattle
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
BMS & Others Partner with WPI 06/09/11 Boston
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank 06/03/11 San Diego
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs 05/12/11 Boston
Roche Vet Takes CEO Job at Boston’s Enlight Biosciences 04/12/11 Boston
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
SeaGen Inks Abbott Deal 03/22/11 Seattle
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder 02/22/11 Boston
CalciMedica Moves Psoriasis Drug Into Clinic, Pockets $6M 02/17/11 San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug 01/27/11 San Diego
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug 01/21/11 San Diego
Entrega Emerges From Enlight 01/10/11 Boston
How VCs Use Advice from Experts 12/23/10 San Francisco
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug 12/07/10 San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? 11/22/10 San Diego
Complete Genomics Goes Public, 23andMe Raises $22M, Genomic Health’s Dx Vision, & More Bay Area Life Sciences News 11/12/10 San Francisco
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News 11/12/10 Boston
Kamen Joins Third Rock Ventures 11/10/10 Boston
Amgen, Abbott Win BayBio Awards 11/05/10 San Francisco
Page 2 of 4 « previous page · next page »